Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rezolute, Inc.

3.73
+0.03000.81%
Volume:433.13K
Turnover:1.62M
Market Cap:318.85M
PE:-3.18
High:3.83
Open:3.75
Low:3.61
Close:3.70
Loading ...

Sector Update: Health Care Stocks Lower Monday Afternoon

MT Newswires Live
·
06 May

Rezolute Gets US FDA Breakthrough Therapy Designation for Hypoglycemia Treatment

MT Newswires Live
·
05 May

Analysts Are Bullish on These Healthcare Stocks: Capricor Therapeutics (CAPR), Rezolute (RZLT)

TIPRANKS
·
05 May

Rezolute Receives Breakthrough Therapy Designation From FDA for Ersodetug in the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism

THOMSON REUTERS
·
05 May

Rezolute Inc - Registrational Study of Ersodetug to Start Mid-2025

THOMSON REUTERS
·
05 May

Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism

GlobeNewswire
·
05 May

Rezolute to Participate in Upcoming Investor Conferences

GlobeNewswire
·
01 May

Rezolute Price Target Maintained With a $14.00/Share by HC Wainwright & Co.

Dow Jones
·
29 Apr

H.C. Wainwright keeps Buy on Rezolute after no changes to sunRIZE sample size

TIPRANKS
·
28 Apr

Rezolute, Inc. Announces Closing of Underwritten Offering

GlobeNewswire
·
26 Apr

Maxim Group Sticks to Its Buy Rating for Rezolute (RZLT)

TIPRANKS
·
25 Apr

Rezolute Shares Rise After Recommendation to Continue Phase 3 Ersodetug Study

Dow Jones
·
23 Apr

Rezolute Prices $90 Million Securities Offering

MT Newswires Live
·
23 Apr

Rezolute Gets Independent DMC's Positive Recommendation to Continue Ersodetug Study -- Shares Surge Pre-Bell

MT Newswires Live
·
23 Apr

BRIEF-Rezolute Announces Pricing Of Offering Of $90 Million Of Common Stock And Pre-Funded Warrants

Reuters
·
23 Apr

Rezolute Announces Pricing of Offering of $90 Million of Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
23 Apr

Rezolute Inc - Prices Underwritten Offering of 20.8 Mln Shares at $3.25 Each

THOMSON REUTERS
·
23 Apr

Rezolute Announces Pricing of Offering of $90 Million of Common Stock and Pre-Funded Warrants

GlobeNewswire
·
23 Apr

Rezolute Announces Positive Recommendation After Independent Interim Analysis of Phase 3 sunRIZE Study of Ersodetug in Congenital Hyperinsulinism (“HI”)

GlobeNewswire
·
23 Apr

Is Rezolute (NASDAQ:RZLT) In A Good Position To Deliver On Growth Plans?

Simply Wall St.
·
22 Apr